Related Articles for PubMed (Select 11806782)

The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?

Waters D, Schwartz GG, Olsson AG.

Curr Control Trials Cardiovasc Med. 2001;2(3):111-114.

PMID: 11806782 [PubMed - as supplied by publisher]

Related Articles Free article in PMC

Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events.

Arca M, Gaspardone A.

Drugs. 2007;67 Suppl 1:29-42. Review.

PMID: 17910519 [PubMed - indexed for MEDLINE]

Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial.

Schwartz GG, Olsson AG, Szarek M, Sasiela WJ.

Diabetes Care. 2005 Oct;28(10):2508-13.

PMID: 16186288 [PubMed - indexed for MEDLINE]

Effects of high-dose atorvastatin in patients > or =65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering [MIRACL] study).

Olsson AG, Schwartz GG, Szarek M, Luo D, Jamieson MJ.

Am J Cardiol. 2007 Mar 1;99(5):632-5. Epub 2007 Jan 9.

PMID: 17317362 [PubMed - indexed for MEDLINE]

10:

Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome.

Arca M.

Drugs. 2007;67 Suppl 1:43-54. Review.

PMID: 17910520 [PubMed - indexed for MEDLINE]

11:

A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.

Buller N, Gillen D, Casciano R, Doyle J, Wilson K.

Pharmacoeconomics. 2003;21 Suppl 1:25-32.

PMID: 12648032 [PubMed - indexed for MEDLINE]

12:

[Meeting report. "MIRACL" study of "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering"]

Scheen AJ.

Rev Med Liege. 2000 Dec;55(12):1064-6. French.

PMID: 11205194 [PubMed - indexed for MEDLINE]

13:

Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.

Gresser U, Gathof BS.

Eur J Med Res. 2004 Jan 26;9(1):1-17. Review.

PMID: 14766335 [PubMed - indexed for MEDLINE]

14:

Atorvastatin: its clinical role in cerebrovascular prevention.

Gaspardone A, Arca M.

Drugs. 2007;67 Suppl 1:55-62. Review.

PMID: 17910521 [PubMed - indexed for MEDLINE]

15:

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J; Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group.

JAMA. 2005 Nov 16;294(19):2437-45. Erratum in: JAMA. 2005 Dec 28;294(24):3092.

PMID: 16287954 [PubMed - indexed for MEDLINE]

16:

Early initiation of treatment with statins in acute coronary syndromes.

Olsson AG, Schwartz GG.

Ann Med. 2002;34(1):37-41. Review.

PMID: 12014432 [PubMed - indexed for MEDLINE]

17:

Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial.

Rouleau J.

Am J Med. 2005 Dec;118 Suppl 12A:28-35.

PMID: 16356805 [PubMed - indexed for MEDLINE]

18:

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.

Olsson AG, Schwartz GG, Szarek M, Sasiela WJ, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A.

Eur Heart J. 2005 May;26(9):890-6. Epub 2005 Mar 11.

PMID: 15764620 [PubMed - indexed for MEDLINE]

19:

Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study.

Deedwania P, Barter P, Carmena R, Fruchart JC, Grundy SM, Haffner S, Kastelein JJ, LaRosa JC, Schachner H, Shepherd J, Waters DD; Treating to New Targets Investigators.

Lancet. 2006 Sep 9;368(9539):919-28.

PMID: 16962881 [PubMed - indexed for MEDLINE]

20:

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators.

N Engl J Med. 2004 Apr 8;350(15):1495-504. Epub 2004 Mar 8. Erratum in: N Engl J Med. 2006 Feb 16;354(7):778.

PMID: 15007110 [PubMed - indexed for MEDLINE]

Recent Activity